JP2022522166A5 - - Google Patents

Info

Publication number
JP2022522166A5
JP2022522166A5 JP2021549908A JP2021549908A JP2022522166A5 JP 2022522166 A5 JP2022522166 A5 JP 2022522166A5 JP 2021549908 A JP2021549908 A JP 2021549908A JP 2021549908 A JP2021549908 A JP 2021549908A JP 2022522166 A5 JP2022522166 A5 JP 2022522166A5
Authority
JP
Japan
Prior art keywords
sequence
effector
seq
sequence described
shmir
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021549908A
Other languages
English (en)
Japanese (ja)
Other versions
JP7873074B2 (ja
JP2022522166A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2020/050182 external-priority patent/WO2020172720A1/en
Publication of JP2022522166A publication Critical patent/JP2022522166A/ja
Publication of JP2022522166A5 publication Critical patent/JP2022522166A5/ja
Application granted granted Critical
Publication of JP7873074B2 publication Critical patent/JP7873074B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021549908A 2019-02-28 2020-02-28 眼咽頭型筋ジストロフィー(opmd)を治療するための組成物及び方法 Active JP7873074B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962812187P 2019-02-28 2019-02-28
US62/812,187 2019-02-28
PCT/AU2020/050182 WO2020172720A1 (en) 2019-02-28 2020-02-28 Compositions and methods for treating oculopharyngeal muscular dystrophy (opmd)

Publications (3)

Publication Number Publication Date
JP2022522166A JP2022522166A (ja) 2022-04-14
JP2022522166A5 true JP2022522166A5 (enExample) 2023-03-03
JP7873074B2 JP7873074B2 (ja) 2026-06-11

Family

ID=72238736

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021549908A Active JP7873074B2 (ja) 2019-02-28 2020-02-28 眼咽頭型筋ジストロフィー(opmd)を治療するための組成物及び方法

Country Status (12)

Country Link
US (1) US20220098614A1 (enExample)
EP (1) EP3931317A4 (enExample)
JP (1) JP7873074B2 (enExample)
KR (1) KR102959609B1 (enExample)
CN (2) CN113631706A (enExample)
AU (1) AU2020229886B2 (enExample)
BR (1) BR112021017054A2 (enExample)
CA (1) CA3130221A1 (enExample)
IL (1) IL285841A (enExample)
MX (1) MX2021010412A (enExample)
SG (1) SG11202108469XA (enExample)
WO (1) WO2020172720A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3866859A4 (en) * 2018-10-17 2023-08-09 Benitec IP Holdings Inc. METHODS OF TREATMENT FOR OCULOPHARYNGEAL MUSCULAR DYSTROPHY (OPMD)
EP4493703A4 (en) * 2022-03-18 2026-08-05 Univ Florida METHODS AND COMPOSITIONS FOR TREATING TMEM43-RELATED CARDIOMYOPATHY WITH A VIRAL VECTOR
KR20260030147A (ko) * 2023-06-28 2026-03-05 베니텍 아이피 홀딩스 아이엔씨. 인두 근육에 치료 조성물을 투여하기 위한 장치 및 방법
WO2026011009A1 (en) * 2024-07-02 2026-01-08 Kate Therapeutics, Inc. Compositions and methods for muscle disorders

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4745051A (en) 1983-05-27 1988-05-17 The Texas A&M University System Method for producing a recombinant baculovirus expression vector
JPH11514853A (ja) 1995-09-08 1999-12-21 ジエンザイム コーポレイション 遺伝子治療のための改良されたaavベクター
US7208315B2 (en) 2000-01-05 2007-04-24 Fred Hutchinson Cancer Research Center Compositions and methods for efficient AAV vector production
EP1390490B1 (en) 2001-05-24 2009-04-15 Genzyme Corporation Muscle-specific expression vectors
US6723551B2 (en) 2001-11-09 2004-04-20 The United States Of America As Represented By The Department Of Health And Human Services Production of adeno-associated virus in insect cells
EP1572893B1 (en) 2001-11-09 2009-01-07 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY of the DEPARTMENT OF HEALTH AND HUMAN SERVICES Production of adeno-associated virus in insect cells
WO2003074714A1 (en) 2002-03-05 2003-09-12 Stichting Voor De Technische Wetenschappen Baculovirus expression system
US20060166363A1 (en) * 2004-01-27 2006-07-27 Sergei Zolotukhin Modified baculovirus expression system for production of pseudotyped rAAV vector
US8008468B2 (en) 2005-02-16 2011-08-30 Benitec, Inc. RNAi expression constructs with liver-specific enhancer/promoter
PT3272872T (pt) 2005-10-20 2020-06-26 Uniqure Ip Bv Vetores aav melhorados produzidos em células de insetos
WO2007120533A2 (en) 2006-03-30 2007-10-25 The Board Of Trustees Of The Leland Stanford Junior University Minigene expression cassette
CN101528916B (zh) 2006-04-28 2013-09-04 宾夕法尼亚大学托管会 规模可调的aav生产方法
WO2007148971A2 (en) 2006-06-21 2007-12-27 Amsterdam Molecular Therapeutics B.V. Vectors with modified initiation codon for the translation of aav-rep78 useful for production of aav in insect cells
EP2242840B1 (en) 2008-01-29 2019-07-24 Applied Genetic Technologies Corporation Recombinant adeno-associated virus production using bhk cells in suspension
RU2664471C2 (ru) * 2013-07-26 2018-08-17 Юниверсити Оф Айова Рисерч Фаундейшн Способы и композиции для лечения болезней мозга
US11078464B2 (en) 2013-08-30 2021-08-03 Amgen Inc. High titer recombinant AAV vector production in adherent and suspension cells
CN104815338A (zh) * 2015-05-01 2015-08-05 许瑞安 一种携带kal基因重组腺相关病毒载体的基因治疗药物
CA3012699C (en) 2016-04-21 2023-11-21 Virovek, Inc Aav production in insect cells, methods and compositions therefor
KR102495222B1 (ko) * 2016-12-14 2023-02-09 베니텍 아이피 홀딩스 아이엔씨. 안구인두근위축증 (opmd)의 치료제 및 이의 사용
EP3575398A4 (en) 2017-01-30 2020-11-11 Nippon Medical School Foundation ADENO-ASSOCIATED VIRUS (AAV) CAPSIDE PROTEIN MUTANT
UY37863A (es) 2017-08-31 2019-03-29 Benitec Biopharma Ltd Virus adenoasociado (aav) con dominio de fosfolipasa modificado

Similar Documents

Publication Publication Date Title
JP2023527354A5 (enExample)
JP2022500066A5 (enExample)
JP2026027271A5 (enExample)
JP2022530544A5 (enExample)
JP2019519219A5 (enExample)
JP2022517174A5 (enExample)
FI3313991T3 (fi) Muunnettu tekijä IX sekä koostumukset, menetelmät ja käytöt geeninsiirtoa varten soluihin, elimiin ja kudoksiin
JP2021500049A5 (enExample)
JP2020518266A5 (enExample)
JP2021502060A5 (enExample)
IL273261B2 (en) Adeno-associated virus variant capsids and methods of using them
JP2005501557A5 (enExample)
JP2017536116A5 (enExample)
JP2022066336A5 (enExample)
US20220380798A1 (en) AAV Expression Cassette and AAV Vectors Comprising the Same
JP2025507958A5 (enExample)
JP2023553005A5 (enExample)
JP2021534755A5 (enExample)
CN119137273A (zh) 包括工程化核内小RNA(snRNA)的组合物和方法
JP2020535804A5 (enExample)
JP2020503014A5 (enExample)
JP2024543211A5 (enExample)
JP2021511035A5 (enExample)
JP2021525531A5 (enExample)
JP2024119830A5 (enExample)